Fibrinolysis-independent role of plasmin and its activators in the haematopoietic recovery after myeloablation

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 11-12, 2009, Pages 4587-4595

  Tjwa, Marc ^a,b   Moura, Rute ^a,b   Moons, Lieve ^a,b   Plaisance, Stephane ^a,b   Mol, Maria De ^a,b   Jansen, Sandra ^a,b   Dewerchin, Mieke ^a,b   Verfaillie, Catherine ^b   Carmeliet, Peter ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Bone marrow; Extracellular matrix remodelling; Fibrinolysis; Plasmin; Progenitors

Indexed keywords

FIBRINOGEN; FLUOROURACIL; PLASMIN; PLASMINOGEN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANIMAL; ARTICLE; BONE MARROW PURGING; C57BL MOUSE; DRUG EFFECT; EXTRACELLULAR MATRIX; FIBRINOLYSIS; HEMATOPOIESIS; METABOLISM; METHODOLOGY; MOUSE;

ANIMALS; BONE MARROW PURGING; EXTRACELLULAR MATRIX; FIBRINOGEN; FIBRINOLYSIN; FIBRINOLYSIS; FLUOROURACIL; HEMATOPOIESIS; MICE; MICE, INBRED C57BL; PLASMINOGEN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

MUS;

EID: 77951151605     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00521.x     Document Type: Article

References (36)

1. Yin T, Li L. The stem cell niches in bone. J Clin Invest. 2006, 116:1195-201.
2. Heissig B, Hattori K, Dias S. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 2002, 109:625-37.
3. Levesque JP, Hendy J, Takamatsu Y. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest. 2003, 111:187-96.
4. Tjwa M, Sidenius N, Moura R. Membrane-anchored uPAR regulates the quiescence, maintenance, engraftment and mobilization of hematopoietic progenitors. J Clin Invest. 2009, 119:1008-18.
5. Collen D. Ham-Wasserman lecture: role of the plasminogen system in fibrin-homeostasis and tissue remodeling. Hematology (Am Soc Hematol Educ Program) 2001, 1-9.
6. Craddock CF, Nakamoto B, Elices M. The role of CS1 moiety of fibronectin in VLA mediated haemopoietic progenitor trafficking. Br J Haematol. 1997, 97:15-21.
7. Scott LM, Priestley GV, Papayannopoulou T. Deletion of alpha4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing. Mol Cell Biol. 2003, 23:9349-60.
8. Voermans C, Rood PM, Hordijk PL. Adhesion molecules involved in transendothelial migration of human hematopoietic progenitor cells. Stem Cells. 2000, 18:435-43.
9. Qian H, Tryggvason K, Jacobsen SE. Contribution of alpha6 integrins to hematopoietic stem and progenitor cell homing to bone marrow and collaboration with alpha4 integrins. Blood. 2006, 107:3503-10.
10. Selleri C, Ragno P, Ricci P. The metastasis-associated 67-kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization. Blood. 2006, 108:2476-84.
11. Hattori K, Heissig B, Wu Y. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat Med. 2002, 8:841-9.
12. Avecilla ST, Hattori K, Heissig B. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med. 2004, 10:64-71.
13. Hatzfeld JA, Hatzfeld A, Maigne J. Fibrinogen and its fragment D stimulate proliferation of human hemopoietic cells in vitro. Proc Natl Acad Sci USA. 1982, 79:6280-4.
14. Zhou YQ, Levesque JP, Hatzfeld A. Fibrinogen potentiates the effect of interleukin-3 on early human hematopoietic progenitors. Blood. 1993, 82:800-6.
15. Weinstein R, Riordan MA, Wenc K. Dual role of fibronectin in hematopoietic differentiation. Blood. 1989, 73:111-6.
16. Larson MK, Watson SP. Regulation of proplatelet formation and platelet release by integrin alpha IIb beta3. Blood. 2006, 108:1509-14.
17. Bugge TH, Kombrinck KW, Flick MJ. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell. 1996, 87:709-19.
18. Heissig B, Lund L, Akiyama H. The plasminogen fibrinolytic pathway is required for hematopoietic regeneration. Cell Stem Cell. 2007, 1:658-70.
19. Hattori N, Degen JL, Sisson TH. Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. J Clin Invest. 2000, 106:1341-50.
20. Suelves M, Vidal B, Serrano AL. uPA deficiency exacerbates muscular dystrophy in MDX mice. J Cell Biol. 2007, 178:1039-51.
21. Inoue A, Seidel MG, Wu W. Slug, a highly conserved zinc finger transcriptional repressor, protects hematopoietic progenitor cells from radiation-induced apoptosis in vivo. Cancer Cell. 2002, 2:279-88.
22. Passegue E, Wagers AJ, Giuriato S. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J Exp Med. 2005, 202:1599-611.
23. Petit I, Szyper-Kravitz M, Nagler A. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol. 2002, 3:687-94.
24. Chen ZL, Strickland S. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell. 1997, 91:917-25.
25. Ledoux D, Papy-Garcia D, Escartin Q. Human plasmin enzymatic activity is inhibited by chemically modified dextrans. J Biol Chem. 2000, 275:29383-90.
26. Kopp HG, Avecilla ST, Hooper AT. Tie2 activation contributes to hemangiogenic regeneration after myelosuppression. Blood. 2005, 106:505-13.
27. Ploplis VA, Carmeliet P, Vazirzadeh S. Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation. 1995, 92:2585-93.
28. Nilsson SK, Debatis ME, Dooner MS. Immunofluorescence characterization of key extracellular matrix proteins in murine bone marrow in situ. J Histochem Cytochem. 1998, 46:371-7.
29. Gu Y, Sorokin L, Durbeej M. Characterization of bone marrow laminins and identification of alpha5-containing laminins as adhesive proteins for multipotent hematopoietic FDCP-Mix cells. Blood. 1999, 93:2533-42.
30. Carmeliet P, Moons L, Lijnen R. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet. 1997, 17:439-44.
31. Heymans S, Luttun A, Nuyens D. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med. 1999, 5:1135-42.
32. Liotta LA, Goldfarb RH, Brundage R. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res. 1981, 41:4629-36.
33. Carmeliet P, Moons L, Herbert JM. Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice. Circ Res. 1997, 81:829-39.
34. Levesque JP, Takamatsu Y, Nilsson SK. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood. 2001, 98:1289-97.
35. Barthel SR, Johansson MW, Annis DS. Cleavage of human 7-domain VCAM-1 (CD106) by thrombin. Thromb Haemost. 2006, 95:873-80.
36. Vidal B, Serrano AL, Tjwa M. Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathway. Genes Dev. 2008, 22:1747-52.